Oneness Biotech Co Ltd 4743
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- TWD 159.00
- Day Range
- TWD 155.50–162.50
- 52-Week Range
- TWD 144.00–253.50
- Bid/Ask
- TWD 159.00 / TWD 159.50
- Market Cap
- TWD 72.47 Bil
- Volume/Avg
- 4.0 Mil / 2.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 979.54
- Dividend Yield (Trailing)
- 0.06%
- Dividend Yield (Forward)
- 0.06%
- Total Yield
- 0.06%
Company Profile
Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 43
- Website
- https://www.onenessbio.com.tw
Comparables
Valuation
|
Metric
|
4743
|
4142
|
6785
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 1,683.28 | 36.34 |
Price/Book Value | 5.39 | 2.20 | 6.73 |
Price/Sales | 979.54 | 7.01 | 32.66 |
Price/Cash Flow | — | — | 38.11 |
Price/Earnings
4743
4142
6785
Financial Strength
|
Metric
|
4743
|
4142
|
6785
|
|---|---|---|---|
Quick Ratio | 39.69 | 1.85 | 34.99 |
Current Ratio | 40.56 | 2.43 | 35.07 |
Interest Coverage | −377.23 | −18.02 | 7,547.70 |
Quick Ratio
4743
4142
6785
Profitability
|
Metric
|
4743
|
4142
|
6785
|
|---|---|---|---|
Return on Assets (Normalized) | −10.96% | −3.83% | 36.40% |
Return on Equity (Normalized) | −11.75% | −6.10% | 41.47% |
Return on Invested Capital (Normalized) | −12.47% | −3.83% | 38.87% |
Return on Assets
4743
4142
6785
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hkrglkfs | Lwvym | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zdhjwlqjs | Hxwbkg | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Wrbqlzgk | Hbvvdm | $106.7 Bil | |
MRNA
| Moderna Inc | Tlbhwsznv | Xzzjq | $50.8 Bil | |
BNTX
| BioNTech SE ADR | Dlvcjxks | Bfwb | $22.4 Bil | |
ARGX
| argenx SE ADR | Yvkmczwvw | Kkn | $22.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Khwjnxb | Lzjjy | $19.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Szpmyfjsf | Mlzkly | $14.6 Bil | |
INCY
| Incyte Corp | Jksqnxtq | Bqkkd | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Kxdpjpxb | Nyshpbn | $12.6 Bil |